Skip to content

Establishment of a personalised diagnosis and treatment system and exploration of the mechanism of subjective tinnitus on the basis of typological classification

Establishment of a personalised diagnosis and treatment system and exploration of the mechanism of subjective tinnitus on the basis of typological classification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100462
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus, stuffy ears, hearing loss

Interventions

Sound therapy group,:None
Nebulised inhalation therapy group:None

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Any gender; 2.adults (>=18 years of age) - Signed informed consent to voluntarily participate in this study; 3.- Tinnitus as the main symptom, can be accompanied by vertigo, hearing loss, hypertension, diabetic disease, high blood fat; 4.- Be able to co-operate with all hearing tests and have good compliance.

Exclusion criteria

Exclusion criteria: 1.Tinnitus caused by pathologies of the outer ear, middle ear, inner ear, and cranial brain, except for other causes; 2.- Except for other-perception tinnitus; 3.- Except for tinnitus caused by organic lesions such as nasopharyngeal carcinoma and acoustic neuroma; 4.- Except for patients with severe liver, kidney or heart disease; 5.- Those with severe mental illness or cognitive impairment that prevents normal communication and affects the accuracy of study data collection; 6.- Those with poor co-operation, e.g. elderly patients with mobility problems, psychiatric patients, etc; 7.- Those suffering from major diseases such as advanced malignant tumour that seriously affects the expectation of survival and cannot participate in the study in its entirety; 8.- Those who have used ototoxic drugs that may affect hearing within the last 3 months.

Design outcomes

Primary

MeasureTime frame
THI;

Secondary

MeasureTime frame
R-value of TMM;

Countries

China

Contacts

Public ContactAnchun Deng

The Second Affiliated Hospital of the Army Medical University

260019300@qq.com+86 23 6875 5611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026